Ferrer is constantly looking for partners in innovation. We are interested in learning about your ideas, molecules, programs in development, co-development opportunities or simply collaboration. We offer full developmental and commercial capabilities.
If you are interested, reach out through one of our innovation gateways:
This program leads innovation in digital health, the meeting point of technology, health, healthcare and society. Through the "Ferrer 4 Future" program, we launch challenges to the entrepreneurial ecosystem and collaborate with technology-based companies to solve them.
Ferrer Open promotes and facilitates contact with the most innovative players in the ecosystem to attract and, in some cases, co-create treatment solutions with added value that fall within Ferrer's areas of specialization: pulmonary vascular and interstitial lung diseases and neurological disorders.
Administering your molecules using our Staccato® One Breath Technology™ (OBT™) could improve safety, efficacy or even result in potential new indications based on its ability to rapidly deliver drug systemically in a non-invasive manner. From more than 400 compounds screened, over 50% of them have been demonstrated to be technically feasible with Staccato technology.